Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
Stanley S SchwartzDiabetes Disease Management at the University of Pennsylvania, Penn Presbyterian Medical Center, Philadelphia Heart Institute, Philadelphia, Pennsylvania, USAAbstract: Insulin resistance and impaired beta-cell function are primary defects that occur early in the course of developme...
Main Author: | Stanley S Schwartz |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-07-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Online Access: | http://www.dovepress.com/pioglitazone-for-the-treatment-of-type-2-diabetes-in-patients-inadequa-a4818 |
Similar Items
-
Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
by: Schwartz S
Published: (2010-07-01) -
Pioglitazone use increases risk of Alzheimer's disease in patients with type 2 diabetes receiving insulin
by: Hsin-Chung Lin, et al.
Published: (2023-04-01) -
Risk management in the treatment of type 2 diabetes with pioglitazone
by: Giuseppe Derosa, et al.
Published: (2009-07-01) -
Treatment intensification with insulin glargine in patients with inadequately controlled type 2 diabetes improves glycaemic control with a high treatment satisfaction and no weight gain
by: Daniela Riebenfeld, et al.
Published: (2015-02-01) -
Insulin Initiation in Insulin-Naïve Korean Type 2 Diabetic Patients Inadequately Controlled on Oral Antidiabetic Drugs in Real-World Practice: The Modality of Insulin Treatment Evaluation Study
by: Sang Soo Kim, et al.
Published: (2015-12-01)